MedTrace Logo

Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers

NCT02182531 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2014-07-14

No results posted yet for this study

Summary

Study to compare the bioavailable fraction of epinastine and pseudoephedrine when administered as a fixed dose combination in tablet form (new pharmaceutical formulation), with that obtained with each of these drugs when administered separately to healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Epinastine

DRUG

Pseudoephedrine

DRUG

Epinastine + Pseudoephedrine combination

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-08-31
Primary Completion
1999-10-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02182531 on ClinicalTrials.gov